Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Citius Oncology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CTOR.
You can purchase shares of Citius Oncology (NASDAQ:CTOR) through any online brokerage.
Other companies in Citius Oncology’s space includes: Zura Bio (NASDAQ:ZURA), Cabaletta Bio (NASDAQ:CABA), Skye Bioscience (NASDAQ:SKYE), OncoCyte (NASDAQ:OCX) and Inozyme Pharma (NASDAQ:INZY).
Citius Oncology has a consensus price target of $4.50.
The stock price for Citius Oncology (NASDAQ: CTOR) is $1.01 last updated March 3, 2025 at 6:16 PM EST.
There are no upcoming dividends for Citius Oncology.
Citius Oncology’s Q2 earnings are confirmed for Wednesday, May 21, 2025.
There is no upcoming split for Citius Oncology.
Citius Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.